About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 68526 record(s)
Req # A-2019-001949
All documentation related to the approval or access of Nurown in Canada or anything of relevance to communication between the Health Canada and Brainstorm Cell Therapeutics regarding Nurown since 2011 until March 24, 2020.Organization: Health Canada
February 2024
Req # A-2021-001996
Briefing notes and attachments regarding the January 17, 2022 authorization of PAXLOVID TM for patients with mild to moderate COVID-19 at high risk of developing serious disease from November 1, 2021 to February 1, 2022.Organization: Health Canada
February 2024
Req # A-2022-000881
All complaints posted against Lifeline Pharmaceuticals - in relation to health product advertising incidents. All information in relation to incidents received by Health Canada and those referred to an Advertising Preclearance Agency (APA) from 2021…Organization: Health Canada
February 2024
Req # A-2022-000919
The Rothmans, Benson & Hedges submission in response to consultation on the proposed Regulations Amending the Tobacco Products Regulations published in the Canada Gazette Part I on June 11, 2022.Organization: Health Canada
February 2024
Req # A-2022-000996
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of…Organization: Health Canada
February 2024
Req # A-2022-001027
The number of prescription requests for psychedelic drugs that were made and the number of prescriptions that were authorized by Health Canada since January 5, 2022.Organization: Health Canada
February 2024
Req # A-2022-001281
All communications with Facebook regarding any discussions/requests to censor/suspend/ban/promote/throttle/shadow ban an account or particular post, since January 1, 2020.Organization: Health Canada
February 2024
Req # A-2022-001559
Internal correspondence related to the Minister of Health‘s letter to provincial and territorial health ministers concerning patients being charged for medically necessary care. Related to the drafting of the letter, requests for information related…Organization: Health Canada
February 2024
Req # A-2022-001649
Advise whether this desmopressin Abbreviated New Drug Submission (ANDS), which was accepted into review on or after March 1, 2022, but before December 1, 2022, has: received a Notice of Deficiency (NOD); received a Notice of Non-Compliance (NON);…Organization: Health Canada
February 2024
Req # A-2023-000171
The Minister’s meeting records in 2022, 2023 with drug companies and/or trade associations which mention drug pricing and/or the Patented Medicine Prices Review Board (PMPRB). Provide 2022, 2023 records prepared for the Minister on PMPRB proposed…Organization: Health Canada
February 2024